Cargando…

Dosimetric analysis and comparison of reduced longitudinal cranial margins of VMAT-IMRT of rectal cancer

BACKGROUND: The cranial border of the target volume (TV) in rectal cancer patients treated with neoadjuvant chemoradiation (nCRT) is mostly defined at the level of L5/S1. However, current studies have shown that relapse cranially of the target volume after neoadjuvant nCRT and surgery is very rare....

Descripción completa

Detalles Bibliográficos
Autores principales: Dapper, Hendrik, Oechsner, Markus, Münch, Stefan, Borm, Kai, Peeken, Jan, Mayinger, Michael, Combs, Stephanie E., Habermehl, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127934/
https://www.ncbi.nlm.nih.gov/pubmed/30189877
http://dx.doi.org/10.1186/s13014-018-1120-0
_version_ 1783353560371560448
author Dapper, Hendrik
Oechsner, Markus
Münch, Stefan
Borm, Kai
Peeken, Jan
Mayinger, Michael
Combs, Stephanie E.
Habermehl, Daniel
author_facet Dapper, Hendrik
Oechsner, Markus
Münch, Stefan
Borm, Kai
Peeken, Jan
Mayinger, Michael
Combs, Stephanie E.
Habermehl, Daniel
author_sort Dapper, Hendrik
collection PubMed
description BACKGROUND: The cranial border of the target volume (TV) in rectal cancer patients treated with neoadjuvant chemoradiation (nCRT) is mostly defined at the level of L5/S1. However, current studies have shown that relapse cranially of the target volume after neoadjuvant nCRT and surgery is very rare. A reduction of cranial TV margins could be reasonable to reduce toxicity to the organs at risk (OAR). In this study we compared the dose distribution to the OAR for different cranial longitudinal margins using a dose-volume histogram (DVH) analysis. METHODS: Ten patients with loco regional advanced rectal cancer were analysed retrospectively. All patients were planned for Volumetric Arc Therapy Radiation Therapy (VMAT). Next to the original PTV (PTV0), three new planning target volumes (PTV) were defined for each patient: The PTV0 reduced by 1 cm, 2 cm and 3 cm on cranial extension. For each PTV a treatment plan with a total dose of 50.4 Gy with daily doses of 1.8 Gy was calculated. Dose to the OAR were evaluated and compared. RESULTS: For the bone marrow, the small bowel and the peritoneal space all clinically relevant relative dose parameters (V10-V50) as well as the Dmedian could be significantly reduced with every cranial target volume reduction of 1 cm. For V10 of the peritoneal space the dose could be nearly halved with a 3 cm shortened TV. After TV reduction of 3 cm also for the urinary bladder a significant dose reduction of the Dmedian could be achieved. CONCLUSIONS: Considering the very low recurrence rates in the TME and IMRT era, the distribution patterns of these relapses as well as the relevant side effects of nCRT, we would agree with existing recommendations of reduction of the cranial target volume in nCRT treated rectal cancer patients.
format Online
Article
Text
id pubmed-6127934
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61279342018-09-10 Dosimetric analysis and comparison of reduced longitudinal cranial margins of VMAT-IMRT of rectal cancer Dapper, Hendrik Oechsner, Markus Münch, Stefan Borm, Kai Peeken, Jan Mayinger, Michael Combs, Stephanie E. Habermehl, Daniel Radiat Oncol Research BACKGROUND: The cranial border of the target volume (TV) in rectal cancer patients treated with neoadjuvant chemoradiation (nCRT) is mostly defined at the level of L5/S1. However, current studies have shown that relapse cranially of the target volume after neoadjuvant nCRT and surgery is very rare. A reduction of cranial TV margins could be reasonable to reduce toxicity to the organs at risk (OAR). In this study we compared the dose distribution to the OAR for different cranial longitudinal margins using a dose-volume histogram (DVH) analysis. METHODS: Ten patients with loco regional advanced rectal cancer were analysed retrospectively. All patients were planned for Volumetric Arc Therapy Radiation Therapy (VMAT). Next to the original PTV (PTV0), three new planning target volumes (PTV) were defined for each patient: The PTV0 reduced by 1 cm, 2 cm and 3 cm on cranial extension. For each PTV a treatment plan with a total dose of 50.4 Gy with daily doses of 1.8 Gy was calculated. Dose to the OAR were evaluated and compared. RESULTS: For the bone marrow, the small bowel and the peritoneal space all clinically relevant relative dose parameters (V10-V50) as well as the Dmedian could be significantly reduced with every cranial target volume reduction of 1 cm. For V10 of the peritoneal space the dose could be nearly halved with a 3 cm shortened TV. After TV reduction of 3 cm also for the urinary bladder a significant dose reduction of the Dmedian could be achieved. CONCLUSIONS: Considering the very low recurrence rates in the TME and IMRT era, the distribution patterns of these relapses as well as the relevant side effects of nCRT, we would agree with existing recommendations of reduction of the cranial target volume in nCRT treated rectal cancer patients. BioMed Central 2018-09-06 /pmc/articles/PMC6127934/ /pubmed/30189877 http://dx.doi.org/10.1186/s13014-018-1120-0 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Dapper, Hendrik
Oechsner, Markus
Münch, Stefan
Borm, Kai
Peeken, Jan
Mayinger, Michael
Combs, Stephanie E.
Habermehl, Daniel
Dosimetric analysis and comparison of reduced longitudinal cranial margins of VMAT-IMRT of rectal cancer
title Dosimetric analysis and comparison of reduced longitudinal cranial margins of VMAT-IMRT of rectal cancer
title_full Dosimetric analysis and comparison of reduced longitudinal cranial margins of VMAT-IMRT of rectal cancer
title_fullStr Dosimetric analysis and comparison of reduced longitudinal cranial margins of VMAT-IMRT of rectal cancer
title_full_unstemmed Dosimetric analysis and comparison of reduced longitudinal cranial margins of VMAT-IMRT of rectal cancer
title_short Dosimetric analysis and comparison of reduced longitudinal cranial margins of VMAT-IMRT of rectal cancer
title_sort dosimetric analysis and comparison of reduced longitudinal cranial margins of vmat-imrt of rectal cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127934/
https://www.ncbi.nlm.nih.gov/pubmed/30189877
http://dx.doi.org/10.1186/s13014-018-1120-0
work_keys_str_mv AT dapperhendrik dosimetricanalysisandcomparisonofreducedlongitudinalcranialmarginsofvmatimrtofrectalcancer
AT oechsnermarkus dosimetricanalysisandcomparisonofreducedlongitudinalcranialmarginsofvmatimrtofrectalcancer
AT munchstefan dosimetricanalysisandcomparisonofreducedlongitudinalcranialmarginsofvmatimrtofrectalcancer
AT bormkai dosimetricanalysisandcomparisonofreducedlongitudinalcranialmarginsofvmatimrtofrectalcancer
AT peekenjan dosimetricanalysisandcomparisonofreducedlongitudinalcranialmarginsofvmatimrtofrectalcancer
AT mayingermichael dosimetricanalysisandcomparisonofreducedlongitudinalcranialmarginsofvmatimrtofrectalcancer
AT combsstephaniee dosimetricanalysisandcomparisonofreducedlongitudinalcranialmarginsofvmatimrtofrectalcancer
AT habermehldaniel dosimetricanalysisandcomparisonofreducedlongitudinalcranialmarginsofvmatimrtofrectalcancer